Similar articles for PMID: 34544765

Year	Number of Results
1996	1
1999	1
2005	1
2006	1
2007	1
2008	2
2009	1
2010	2
2011	3
2012	3
2014	6
2015	5
2016	12
2017	12
2018	12
2019	20
2020	18
2021	22
2022	20
2023	4

1

A Needs Assessment of Persons With Sickle Cell Disease in a Major Medical Center in North Carolina.

Masese RV, Crego N, Douglas C, Rains G, Bonnabeau E, DeMartino T, Shah N, Tanabe P. Masese RV, et al. N C Med J. 2021 Sep-Oct;82(5):312-320. doi: 10.18043/ncm.82.5.312. N C Med J. 2021. PMID: 34544765 Free article.

2

Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers' perspective.

Masese RV, Bulgin D, Douglas C, Shah N, Tanabe P. Masese RV, et al. PLoS One. 2019 May 7;14(5):e0216414. doi: 10.1371/journal.pone.0216414. eCollection 2019. PLoS One. 2019. PMID: 31063506 Free PMC article. Clinical Trial.

3

Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.

Alberts NM, Badawy SM, Hodges J, Estepp JH, Nwosu C, Khan H, Smeltzer MP, Homayouni R, Norell S, Klesges L, Porter JS, Hankins JS. Alberts NM, et al. JMIR Mhealth Uhealth. 2020 May 8;8(5):e14884. doi: 10.2196/14884. JMIR Mhealth Uhealth. 2020. PMID: 32383683 Free PMC article.

4

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study.

Hankins JS, Shah N, DiMartino L, Brambilla D, Fernandez ME, Gibson RW, Gordeuk VR, Lottenberg R, Kutlar A, Melvin C, Simon J, Wun T, Treadwell M, Calhoun C, Baumann A, Potter MB, Klesges L, Bosworth H; Sickle Cell Disease Implementation Consortium. Hankins JS, et al. JMIR Res Protoc. 2020 Jul 14;9(7):e16319. doi: 10.2196/16319. JMIR Res Protoc. 2020. PMID: 32442144 Free PMC article.

5

Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.

Smeltzer MP, Howell KE, Treadwell M, Preiss L, King AA, Glassberg JA, Tanabe P, Badawy SM, DiMartino L, Gibson R, Kanter J, Klesges LM, Hankins JS; Sickle Cell Disease Implementation Consortium. Smeltzer MP, et al. BMJ Open. 2021 Nov 17;11(11):e050880. doi: 10.1136/bmjopen-2021-050880. BMJ Open. 2021. PMID: 34789492 Free PMC article.

6

Interventions for chronic kidney disease in people with sickle cell disease.

Roy NB, Fortin PM, Bull KR, Doree C, Trivella M, Hopewell S, Estcourt LJ. Roy NB, et al. Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2. Cochrane Database Syst Rev. 2017. PMID: 28672087 Free PMC article. Review.

7

Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.

Zumberg MS, Reddy S, Boyette RL, Schwartz RJ, Konrad TR, Lottenberg R. Zumberg MS, et al. Am J Hematol. 2005 Jun;79(2):107-13. doi: 10.1002/ajh.20353. Am J Hematol. 2005. PMID: 15929107 Free article.

8

Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria.

Ofakunrin AO, Okpe ES, Afolaranmi TO, Olaosebikan RR, Kanhu PU, Adekola K, Dami N, Sagay AS. Ofakunrin AO, et al. Afr Health Sci. 2021 Jun;21(2):765-774. doi: 10.4314/ahs.v21i2.36. Afr Health Sci. 2021. PMID: 34795734 Free PMC article.

9

Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.

Lanzkron S, Haywood C Jr, Hassell KL, Rand C. Lanzkron S, et al. J Natl Med Assoc. 2008 Aug;100(8):968-73. J Natl Med Assoc. 2008. PMID: 18717150

10

A Survey-Based Needs Assessment of Barriers to Optimal Sickle Cell Disease Care in the Emergency Department.

Linton EA, Goodin DA, Hankins JS, Kanter J, Preiss L, Simon J, Souffront K, Tanabe P, Gibson R, Hsu LL, King A, Richardsona LD, Glassberg JA; Sickle Cell Disease Implementation Consortium. Linton EA, et al. Ann Emerg Med. 2020 Sep;76(3S):S64-S72. doi: 10.1016/j.annemergmed.2020.08.013. Ann Emerg Med. 2020. PMID: 32928465 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed